Investigation of optimum hemoglobin levels in older patients with chronic kidney disease

Abstract Aim: The aim of the present study is to determine target hemoglobin (Hgb) values ​​in older females and males with chronic kidney disease (CKD) according to best performance in mood, gait and balance, muscle strength and activities of daily living, which are important parameters of geriatric assessment. Method: Patients' age, gender, education level, and comorbidities were recorded. All the participants underwent comprehensive geriatric assessment (CGA) including Basic and Instrumental Activities of Daily Living for functional evaluation, Tinetti Performance-Oriented Assessment of Mobility and Timed Up and Go Test for fall risk, and hand grip strength for muscle strength. Hgb levels and kidney functions were analyzed on the same day as CGA measurements. Receiver Operating Characteristic (ROC) analysis was used to detect the optimum level of Hgb according to the best performance of CGA parameters. Results: 622 elderly CKD patients (69.3% female, 55.7% with anemia) were included. After adjustment for confounders, those with anemia had dynapenia (OR 1.60), high risk of falls (OR 1.60), and decreased functional capacity (OR 1.83) among females and those with anemia had dynapenia (OR 4.31), a high risk of falling (OR 2.42) and decreased functional capacity (OR 2.94) among males. The optimum value of Hgb level is 11.8-12.1 in females and 12.6-12.8 in males according to ROC analysis. Conclusion: Anemia is associated with dynapenia, high risk of falls, and decreased functional capacity in older CKD patients regardless of genericity. To prevent these negative outcomes, Hgb should be kept in the range of 11.8-12.1 in older females with CKD and 12.6-12.8 in older males with CKD. Keywords: Anemia; Chronic kidney disease; Elderly; Hemoglobin.

Investigation of optimum hemoglobin levels in older patients with chronic kidney disease

Kara O, Soysal P, Kiskac M, Smith L, Karışmaz A, Kazancioglu R. Investigation of optimum hemoglobin levels in older patients with chronic kidney disease. Aging Clin Exp Res. 2022 Dec;34(12):3055-3062. doi: 10.1007/s40520-022-02246-1. Epub 2022 Sep 22. PMID: 36136237.

Bu makale 2 Nisan 2024 tarihinde güncellendi. 0 kez okundu.

Yazar
Prof. Dr. Muharrem Kıskaç

1978 yılında Malatya'da doğdum. 1996 yılında İstanbul (Çapa) Tıp Fakültesine birincilikle girdim . 6 yıllık tıp fakültesi eğitimim sonrasında 2002 yılında TUS (Tıpta uzmanlık sınavı) sınavı sonucunda Türkiye 14. sü olarak 1. Tercihim olan S.B. Okmeydanı E.A.H. 'de iç hastalıkları asistanı olarak çalışmaya başladım .2007-2010 yılları arasında Siirt Devlet Hastanesinde mecburi hizmetimi yaptım. 2010 yılında Bezmialem Vakıf Üniversitesi Tıp Fakültesinde çalışmaya başladım. Halen halen aynı fakültede profesör olarak çalışmaktayım.

İlgi alanlarım :Tüm Dahili hastalıkların tanı, takip ve tedavisi , sağlıklı yaşam, sağlıklı beslenme, obezite , antiaging tedavisi Sağlık Bakanlığı yetki sertifikalı olarak Fitoterapi (Bitkisel tedaviler) , Kupa tedavisi (Hacamat), Hirudoterapi (Sülük Tedavisi)

Prof. Dr. Muharrem Kıskaç
Prof. Dr. Muharrem Kıskaç
İstanbul - Dahiliye - İç Hastalıkları
Facebook Twitter Instagram Youtube